Physician profile
Ladd J Scriber
NPI 1467424580
$6,577.94
in general payments reported to CMS, 2019-2025
41 companies · $453 in 2025
The $453 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $796 · 2020: $681 · 2021: $1,413 · 2022: $827 · 2023: $865 · 2024: $1,544 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,761 · Education: $60.99 · Entertainment: $39.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,760.70 |
| Education | $60.99 |
| Entertainment | $39.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,218.25 | 2020-2025 | Aquabeam System, Aquabeam Robotic System |
| Edap Technomed INC | $801.45 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $364.66 | 2019-2024 | Provenge |
| Myriad Genetic Laboratories, INC. | $340.85 | 2020-2025 | Prolaris, Myrisk |
| Janssen Biotech, INC. | $320.20 | 2019-2023 | Erleada |
| Abbvie INC. | $306.15 | 2019-2025 | Botox, Lupron Depot |
| Coloplast Corp | $306.00 | 2019-2024 | Speedicath |
| Astellas Pharma US INC | $300.13 | 2019-2024 | Xtandi, Myrbetriq |
| Pfizer INC. | $282.58 | 2019-2025 | |
| Myovant Sciences INC. | $266.14 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $161.06 | 2019-2023 | Xiaflex, Aveed |
| Olympus America INC. | $160.48 | 2019-2025 | Itind System |
| Medtronic, INC. | $160.21 | 2021-2025 | Altaviva, Interstim |
| Sumitomo Pharma America, INC. | $154.31 | 2023-2025 | Orgovyx, Gemtesa |
| Blue Earth Diagnostics | $152.67 | 2019-2023 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $110.65 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $103.50 | 2019-2022 | |
| Urogen Pharma, INC. | $100.41 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $84.83 | 2022 | |
| Merck Sharp & Dohme LLC | $82.09 | 2020-2025 | Keytruda, Lynparza, Bridion |
| Boston Scientific Corporation | $66.44 | 2023-2024 | Advantage System, Rezum Generator |
| Teleflex LLC | $59.05 | 2023-2024 | Urolift |
| Axonics, INC. | $59.00 | 2022-2024 | Bulkamid |
| Endo USA, INC. | $57.88 | 2024 | Xiaflex |
| Neotract INC. | $55.31 | 2019-2020 | |
| Medtronic USA, INC. | $52.75 | 2019-2020 | |
| C. R. Bard, INC. & Subsidiaries | $49.71 | 2019 | |
| Conmed Corporation | $48.68 | 2025 | Airseal |
| Abiomed | $46.53 | 2023-2024 | Impella |
| Allergan, INC. | $45.90 | 2019-2021 | |
| Antares Pharma, INC. | $41.71 | 2023-2024 | Xyosted, Tlando, Nocdurna |
| Tolmar, INC. | $33.39 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $32.44 | 2019-2020 | |
| Cvrx, INC. | $29.62 | 2023 | Barostim Neo System |
| Melinta Therapeutics, LLC | $23.20 | 2019 | |
| Abc Home Medical Supply, INC. | $21.47 | 2025 | |
| Convatec INC. | $18.90 | 2023 | |
| Hollister Incorporated | $16.96 | 2023 | Vapro Pocket |
| Civco Medical Instruments | $15.74 | 2025 | |
| Photocure INC | $13.48 | 2024 | Cysview |
| Angiodynamics, INC. | $13.16 | 2024 | Nanoknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ladd Scriber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.